Introduction.
The hydrolysis of stored triglycerides (TG) to free fatty acids in adipose tissue is an important mechanism for supplying energy to peripheral tissues in times of demand (Duncan et al., 2007) . Lipolysis is under tight homeostatic control by numerous mechanisms that affect the expression and activity of core lipolytic proteins (Duncan et al., 2007; Jaworski et al., 2007; Nielsen et al., 2014) . Dysfunctions in one or more of these factors can lead to elevated levels of circulating free fatty acids, which are associated with a number of metabolic disturbances including insulin resistance, hepatic steatosis, and dyslipidemia (Roden et al., 1996; Boden, 1998; Kahn et al., 2006; Petta et al., 2016) . Thus, a thorough understanding of both extrinsic and intrinsic regulation of lipolysis is of great interest for treating metabolic disease.
The current understanding of post-translational regulation of adipocyte lipolysis is largely based on acute regulation by activators and inhibitors of the protein kinase A (PKA) signaling pathway. In this model, extracellular signals including hormones and catecholamines bind surface G-protein receptors that couple to the generation, inhibition, or degradation of cyclic AMP (cAMP), a direct activator of PKA (Carmen and Victor, 2006; Granneman and Moore, 2008; Nielsen et al., 2014) . Mechanistically, lipolysis is initiated when PKA phosphorylates a protein complex containing the lipid droplet scaffold protein perilipin-1 (PLIN1) and α-β-hydrolase domain containing 5 (ABHD5, also known as CGI-58), a critical activator of adipose triglyceride lipase (ATGL) Schweiger et al., 2006) . In the current model, PKA-dependent phosphorylation of PLIN1 releases ABHD5 thereby allowing activation of ATGL, the first and rate-limiting enzyme in TG hydrolysis (Zimmermann et al., 2004; Granneman et al., 2007; Granneman et al., 2009a) . PKA also phosphorylates hormone sensitive lipase (HSL), which then translocates to the lipid droplet surface where it preferentially This article has not been copyedited and formatted. The final version may differ from this version.
JPET Fast Forward. Published on as DOI: 10.1124 at ASPET Journals on November 13, 2017 jpet.aspetjournals.org Downloaded from JPET #243253 6 hydrolyzes diglyceride (DG) substrates (Egan et al., 1992; Clifford et al., 2000; Holm, 2003; Sztalryd et al., 2003) . Thus, the current model postulates that PKA-dependent activation of ATGL and HSL comprise the central mechanism for regulating lipolysis by extracellular signals.
Our laboratory recently completed a high throughput screen for compounds that activate lipolysis by directly dissociating complexes of ABHD5 with PLIN1 and PLIN5 (Sanders et al., 2015) . We discovered two structurally-distinct chemical scaffolds represented by the compounds SR-4995 and SR-4559 that directly bind ABHD5 and stimulate lipolysis by releasing it from PLIN, thereby mimicking the effects of extracellular signaling in the absence of PKAdependent phosphorylation of HSL and PLIN. Subsequent work indicated that ABHD5 contains an allosteric binding site that regulates its interactions with PLIN proteins and provides a mechanism of lipolysis control that can be independent of extracellular signaling (Sanders et al., 2015) .
In the present study we utilized these novel synthetic ABHD5 ligands as well as a new structural analogue of the thiazatricyclo-urea compound, SR-4995 to probe the integration of lipolysis controlled by canonical β-adrenergic receptors (ADRB) and direct activators of ABHD5 in differentiated white (3T3-L1) and brown adipocytes (BA), as well as in adipose tissue explants. We further evaluated the relative involvement of HSL and ATGL in mediating ABHD5-dependent lipolysis using pharmacological inhibitors. Findings from this study provide evidence that direct activation of ABHD5 can lead to complete TG hydrolysis and lend further support for the central role of ABHD5-PLIN interactions in the control of basal and stimulated lipase activity.
This article has not been copyedited and formatted. The final version may differ from this version. (Grand Island, NY) , and isoproterenol, KrebsRinger bicarbonate buffer (KRBB), 3-isobutyl-1-methylxanthine (IBMX), dexamethasone, free glycerol reagent, 3,3′,5-Triiodo-L-thyronine (T3) and bovine insulin from Sigma-Aldrich (St.
Louis, MO). Antibodies to detect phosphorylated-HSL (Ser-563) and total HSL were purchased from Cell Signaling (Danvers, MA), a PLIN1 antibody was purchased from Everest Biotech (Ramona, CA), phospho-specific PLIN1 antibody (Ser-522) from Vala Sciences (San Diego, CA), and secondary horseradish peroxidase antibodies from Jackson Labs (Bar Harbor, ME). (Lowe et al., 2004; Claus et al., 2005) was provided by Bayer (Whippany, NJ).
The ABHD5 ligands SR-4995, SR-4559, and SR-3420 were synthesized at Scripps Research Institute (Jupiter, FL). SR-4995, a thiaza-tricyclo-urea and SR-4559, a member of the sulfonyl piperazine class of compounds have been described previously (Sanders et al., 2015) . SR-3420 is a structural analogue of SR-4995 and was designed to increase the lipolysis efficacy of Additional sources of reagents are specified within the text below.
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JPET #243253 8 3T3-L1 Cell Culture and Differentiation. 3T3-L1 preadipocytes were purchased from the American Type Culture Collection (Manassas, VA, USA), and maintained in Dulbecco's Minimal Essential Medium (DMEM) supplemented with 10% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin (growth media). For each experiment, cells were sub-cultured using 0.25% trypsin-ethylenediaminetetraacetic acid (EDTA) and seeded onto tissue culture plates. Forty eight hours after reaching confluency, differentiation was initiated by treating cells with growth media containing 1 µg/mL insulin, 0.5 mM IBMX, and 1 mM dexamethasone. At 2 and 4 days post-induction, media was replaced with growth media containing 1 µg/mL insulin, and on day 6 with growth medium alone. Unless otherwise specified, treatments were initiated 8 days postinduction.
Brown Preadipocyte (BA) Culture and Differentiation. A brown preadipocyte cell line was generated as previously described (Klein et al., 1999; Mottillo et al., 2016) and provided by the laboratory of Dr. Gregory Steinberg (McMaster University, Hamilton, ON, CA). Briefly, preadipocytes were isolated from the interscapular brown adipose tissue of 3-4 day old FVB/NJ female pups using collagenase digestion. Isolated cells were then cultured and immortalized by infection with the SV40 large T-antigen, followed by selection with puromycin. Preadipocytes were cultured and maintained in DMEM growth medium as described above. To induce differentiation, cells were trypsinized and then sub-cultured onto plates in growth media supplemented with 1 nM T3 and 20 nM insulin (differentiation medium). Upon reaching confluency, preadipocytes were treated in differentiation medium containing 5 mM dexamethasone, 0.5 mM IBMX, and 0.125 mM indomethacin (induction medium) for 48 hours. The concentration of Atglistatin and BAY were selected based on previous dose-response studies and demonstrated to inhibit both basal and stimulated fatty acid release (Claus et al., 2005; Mayer et al., 2013) . At one and three hours following the initial treatment, an aliquot of culture medium was collected for determination of non-esterified free fatty acids (NEFA) and glycerol.
To evaluate the effect of insulin pre-treatment on compound-mediated lipolysis, differentiated 3T3-L1 and BA cells were washed once in PBS, and incubated in serum-free DMEM for 2 hours. Cells were washed again in PBS and then pre-incubated in KRBB medium containing 1% FF-BSA either alone or containing 100 nM of insulin for 30 minutes, after which DMSO, isoproterenol, or ABHD5 ligands were added directly to the media at concentrations indicated in the individual figure legends. The effect of β-adrenergic receptor pre-stimulation on compound-mediated lipolysis was also assessed. Briefly, 100 nM of isoproterenol or vehicle control was added directly to wells containing DMEM. Following a pre-incubation period of 2.5 (3T3-L1) or 3 hours (BA), cells were washed three times in PBS, and then treated with either Non-esterified fatty acids were quantified in the media using a NEFA assay kit (Wako Diagnostics) and the fluorogenic substrate, Amplex Red (Cayman Chemical; Ann Arbor, MI).
Fluorescence intensities were quantified using a Clariostar plate reader (BMG LabTech; Ortenberg, Germany) with an excitation/emission maxima of 545/600 nm. Glycerol release was estimated in the culture medium using free glycerol reagent (Sigma-Aldrich; St. Louis, MO) according to the manufacturers' instructions. containing Halt protease and phosphatase inhibitors (ThermoFisher). Cells were sonicated briefly, and lysates clarified by centrifugation at 13,000 x g for 15 min at 4 °C. Protein concentrations were determined in the lysates using the bicinchoninic acid assay (ThermoFisher), and immunoblotting was performed using Nusep gradient gels (VWR; Radnor, PA), as described previously (Rondini et al., 2014) . Blots were then probed with antibodies to detect phospho-HSL (Ser-563), total HSL, phospho-specific PLIN1 (Ser-522), or total PLIN1 diluted in Trisbuffered saline containing 5% FF-BSA. Following an overnight incubation, immunoreactive bands were detected using peroxidase-conjugated secondary antibodies and enhanced chemiluminescence (ThermoFisher), and images captured with a digital imaging system (Azure 
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Biosystems; Dublin, CA). For each experiment, an aliquot of the media was saved for NEFA determination.
Statistical Analysis. Statistical analyses were conducted using SigmaPlot software (Version 10.0; Point Richmond, CA). Lipolysis data were analyzed using a one or two way analysis of variance (ANOVA), and when significant differences were detected (P<0.05), individual comparisons were made using the Student-Newman-Keuls test. Where appropriate, data were log-transformed prior to analysis to fit the assumptions of ANOVA. Percent inhibition was analyzed using the Kruskal-Wallis test and individual comparisons made using StudentNewman-Keuls. All results are presented as mean ± S.E.M.
Results.
ADRB and ABHD5 converge on a common mechanism for TG hydrolysis. To determine whether ABHD5 ligands stimulate lipolysis independently of cAMP/PKA signaling, differentiated 3T3-L1 adipocytes (a model of white adipocytes) and differentiated immortalized brown adipocytes (BA) were treated with vehicle, isoproterenol (10 nM (BA) or 10 µM (3T3-L1)) or 20 µM of an ABHD5 ligand for 1 hour, after which media was collected for NEFA determination and cell lysates probed for PKA-dependent phosphorylation of perilipin-1 (PLIN1, Ser-522) and hormone sensitive lipase (HSL; Ser-563). As shown in Figure 1A (Fig. 1C-E) . These data support a mechanism whereby ABHD5 ligands act to dissociate ABHD5/PLIN1 complexes but do not themselves directly affect the ability of dissociated ABHD5 to activate ATGL (Sanders et al., 2015) . Further, our data indicate that isoproterenol and synthetic ABHD5 ligands activate lipolysis by targeting a common pool of ABHD5.
Ligand-mediated activation of ABHD5 leads to complete TG hydrolysis and involves both ATGL and HSL. Triglyceride lipolysis is thought to be mediated by the combined action of ATGL and HSL, which comprise > 90% of TG activity in adipose tissue . ATGL exhibits high specificity for TG, and therefore thought to be the first and rate- 14 limiting enzyme in TG hydrolysis (Zimmermann et al., 2004) . Although HSL can hydrolyze both TG and diglycerides (DG), the activity towards the former is approximately 11-fold lower than that for DG substrates (Osterlund et al., 1996; Holm, 2003) . Importantly, each of these steps is thought to require PKA-dependent phosphorylation of PLIN1 and HSL, respectively (Granneman and Moore, 2008) . Based on this model, it would be predicted that ABHD5 ligands would only activate ATGL, and thus generate a fraction of the NEFA released by isoproterenol and no glycerol, which requires PKA-dependent HSL activation.
We therefore evaluated the effect of ISO and ABHD5 ligands on NEFA and glycerol release in differentiated 3T3-L1 and BA cells stimulated in culture for 3 hours and results are presented in Fig 2. We found that ABHD5 ligands generated significant amounts of NEFA and glycerol in 3T3-L1 adipocytes ( Fig. 2A,C) as well as BA cells (Fig. 2B,D) in a manner that was highly similar to that produced by isoproterenol. In general, both basal and stimulated lipolysis were higher in 3T3-L1 cells, and further increased by ~2.5 and ~2-fold in 3T3-L1 and BA cells, respectively after 3 hours of stimulation ( Fig. 2A,B) . Complete hydrolysis of triglyceride would theoretically generate 3 mol of FFA per mol glycerol in the absence of significant reesterification. In the case of 3T3-L1 cells, activation of lipolysis by isoproterenol or ABHD5 ligands resulted in the expected molar ratio of 3:1 (Fig. 2E) . In BA, the ABHD5 ligands SR-3420 and SR-4995 also elevated the FFA/glycerol ratio compared to vehicle control, whereas isoproterenol and SR-4559 were somewhat less effective (Fig. 2F) .
To further corroborate findings from our in vitro cellular models, we tested the effects of ISO and ABHD5 ligands on lipolysis in explants of gonadal white adipose (gWAT) and interscapular brown adipose (iBAT) tissue isolated from male (n=7) and female (n=4) mice (Fig.   3) . In general, gWAT cultures from females tended to have lower basal NEFA release than 15 males, however, overall responses to treatments were similar between sexes and therefore results were combined for analysis. There was no effect of sex on NEFA levels in iBAT cultures or on glycerol release from either tissue (data not shown). As shown in Fig. 3 , both isoproterenol and ABHD5 ligands stimulated NEFA release in a manner similar to that observed in cultured cells (Fig. 3A,C) , with ISO responses generally stronger than ABHD5 ligands in gWAT. Glycerol measurements closely paralleled the changes observed with NEFA, with ISO, SR-3420, and SR-4995 being more potent in stimulating glycerol release than SR-4559 (Fig. 3B,D) . The molar ratio of FFA to glycerol observed in organ culture was closer to 1:1 for all treatments, suggesting a more efficient re-esterification and/or metabolism of FFA in tissues compared to that observed in cultured cells. Nonetheless, findings of complete TG hydrolysis as evidenced by an increase in glycerol further support the results from cultured adipocytes.
Because ATGL is thought to be a specific TG lipase (i.e., lacking DG or MG lipase activity), observations from our in vitro and ex vivo studies indicate that additional lipases may contribute to ABHD5-mediated release of NEFA and glycerol. To investigate this possibility further, we used selective pharmacological inhibitors of ATGL (Atglistatin) and HSL (BAY) and further evaluated the effect of ABHD5 ligands on NEFA release in 3T3-L1 and BA cells ( Figure   4 and Table 1 ). As expected, the combined inhibition of ATGL and HSL virtually eliminated NEFA efflux induced by ISO and ABHD5 ligands in both 3T3-L1 and BA cells (Control values were redrawn from Figure 2 , which was performed as part of the same experiment). BAY alone was sufficient to strongly inhibit NEFA efflux from 3T3-L1 cells and this effect was indistinguishable between ISO and ABHD5 ligands (Fig. 4A) . Interestingly, whereas Atglistatin strongly suppressed ABHD5 ligand-induced lipolysis (70-77%) after 3 hr, it was significantly less effective (54%) in suppressing that induced by ISO (Fig. 4A, Table 1 ). The Atglistatin- 16 resistant component of NEFA release was fully suppressed by BAY, indicating that HSL contributes significantly to TG hydrolysis following PKA activation, and similarly that basal HSL activity is sufficient to hydrolyze DG generated by selective ABHD5/ATGL activation.
Further, under conditions where basal or stimulated HSL activity was suppressed (i.e., in the presence of BAY), synthetic ABHD5 ligands were as effective as ISO in inducing ATGLdependent lipolysis. In BA cells, lipolysis was generally more sensitive to ATGL inhibition compared to that observed in 3T3-L1 cells and significantly less sensitive to HSL inhibition (Fig.   4B ). We note that 3T3-L1 adipocytes (but not BA cells) exhibited a significant component (17-25%) of compound-induced lipolysis that was resistant to Atglistatin, yet sensitive to BAY, indicating HSL-dependent, ATGL-independent stimulation of lipolysis by ABHD5.
Nonetheless, the overall pattern of NEFA release during selective lipase inhibition was highly similar between ISO and ABHD5 ligands, especially for SR-3420. Together, these results indicate that ATGL and HSL are critical lipases for ISO-and ABHD5-ligand induced activation and that the relative contribution of these lipases is remarkably similar for a given cell type.
Insulin differentially inhibits lipolysis mediated by cAMP and ABHD5 ligands in 3T3-L1
and BA cells. Adipocyte lipolysis is under inhibitory control by insulin receptor signaling, and it is thought that this suppression is mediated largely, if not exclusively, by phosphodiesterase 3B, which degrades cAMP, thereby suppressing PKA signaling (Lonnroth and Smith, 1986; Degerman et al., 1998) among activators, results from both cell lines were normalized to the mean of pretreatment control levels, and values expressed as a percentage of these controls. As shown in Figure 5 , insulin sharply suppressed activation of lipolysis by isoproterenol in both 3T3-L1 (Fig. 5A ) and BA cells (Fig. 5B) (P<0.01) . In contrast, insulin failed to suppress lipolysis stimulated by synthetic ABHD5 ligands. These data demonstrate that insulin signaling does not acutely impact lipolysis distal to PLIN1 phosphorylation, and further imply that ABHD5 ligands regulate lipolysis through a mechanism independent of cAMP-mediated signaling.
Lipolysis induced by ABHD5 ligands is unaffected by receptor-mediated desensitization in
3T3-L1 and BA cells. Sustained stimulation of β-adrenergic signaling causes tachyphylaxis of functional responses due to the desensitization of various components in the PKA signaling pathway (Benovic et al., 1988; Lohse et al., 1990) . It was therefore of interest to determine whether ABHD5 ligands could stimulate lipolysis when cells have undergone desensitization to β-adrenergic activation. As shown in Fig. 6 , pretreatment of 3T3-L1 (Fig. 6A ) and BA cells (Fig. 6B) with 100 nM ISO significantly suppressed the lipolysis response to a subsequent challenge by ISO in both cell lines (P<0.05). In sharp contrast, previous exposure to ISO did not affect stimulation of lipolysis by the synthetic ABHD5 ligands.
Discussion.
ABHD5 (also called CGI-58) is a member of the α/β-hydrolase family of proteins (Lefevre et al., 2001) . A central role for ABHD5 in lipolysis was revealed by the finding that inactivating mutations in the CGI-58 gene are causative for Chanarin-Dorfman syndrome, a rare form of neutral lipid storage disease in humans (Lefevre et al., 2001) . Subsequent studies demonstrated that targeted knockdown of ABHD5 in mice increased TG accumulation in various tissues including liver (Brown et al., 2010; Radner et al., 2010) , macrophages (Goeritzer et al., This article has not been copyedited and formatted. The final version may differ from this version. 18 2014), and muscle (Zierler et al., 2013; Xie et al., 2015) , whereas overexpression reduced cellular TG content in some Brown et al., 2007; Badin et al., 2012) , but not all studies (Caviglia et al., 2011) . ABHD5 does not possess intrinsic hydrolytic activity and it is thought to function predominately as a protein co-activator for ATGL Schweiger et al., 2006) , although ATGL-independent functions have also been suggested (Lord and Brown, 2012; Lord et al., 2016) . In the basal state, ABHD5 is localized on the surface of the lipid droplet through direct interaction with PLIN proteins (Subramanian et al., 2004; Yamaguchi et al., 2004; Granneman et al., 2009a) . Activation of PKA by extracellular signals leads to phosphorylation of PLIN1 and ABHD5 (Granneman et al., 2009a; Sahu-Osen et al., 2015) , thereby dissociating ABHD5, which can then bind to and stimulate the activity of ATGL (Subramanian et al., 2004; Yamaguchi et al., 2004) .
Most of what is known regarding ABHD5 is through loss and gain of function studies as well as PKA-dependent regulatory mechanisms. Our laboratory recently reported that ABHD5 is also subject to direct allosteric regulation by endogenous and synthetic ligands that modulate lipolysis independently of extracellular signaling, by mediating the interaction of ABHD5 with PLIN proteins (Sanders et al., 2015) . Although endogenous activating ligands have not been identified, long chain acyl-CoAs are potent antagonist regulators that promote PLIN-ABHD5 interactions, thereby reducing lipolysis (Granneman et al., 2009b; Sanders et al., 2015) . The discovery of synthetic ABHD5 ligands therefore allows further dissection of PKA-dependent and allosteric-mediated effects of ABHD5 on TG catabolism, including how activation by extracellular and intracellular signals are integrated, the lipases that are engaged, and the products that are generated. 
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ABHD5 is abundantly expressed in differentiated adipocytes (Subramanian et al., 2004; Yamaguchi et al., 2004; Lass et al., 2006) , and in the current study we utilized cellular models of both white (3T3-L1) and brown adipocytes (BA) to determine whether extracellular and intracellular signals interact in mediating ABHD5-dependent lipolysis. We found that synthetic ABHD5 ligands had no effect on the potency or maximal lipolysis efficacy of the β-adrenergic receptor (ADRB) agonist, isoproterenol (ISO), suggesting both converge on a common pathway for lipolysis regulation. Stated differently, these results indicate that ABHD5 plays a central role in integrating extracellular and intracellular signals that control adipocyte lipolysis. Because ABHD5 clearly lies downstream of PKA activation, its allosteric regulation by synthetic and endogenous ligands provides a means of rapidly adjusting fatty acid supply to internal demand that can occur independently of extracellular signals.
Results from the current study also indicate that direct activation of ABHD5 results in the complete hydrolysis of TG to free fatty acids and glycerol. Indeed, the relative efflux of fatty acids and glycerol induced by the more potent ABHD5 ligand, SR-3420 was equal to that produced by isoproterenol, despite differences in PKA-dependent phosphorylation of HSL. The findings that ABHD5 ligands stimulate complete TG hydrolysis were also further corroborated ex vivo in organ cultures of gWAT and iBAT. Although ABHD5 is integral for ATGL lipase activity , pharmacological analysis demonstrated that HSL can account for a significant portion of mobilized fatty acids released under basal conditions and during direct these lipases in TG metabolism . Importantly, that synthetic ABHD5 ligands elicited lipolysis responses to an extent similar to that observed with isoproterenol further reinforces the importance of ABHD5-PLIN interactions in controlling lipase activity.
The finding that HSL can contribute significantly to both basal and ABHD5-dependent lipolysis in our study was somewhat surprising given previous work indicating the importance of PKA-dependent phosphorylation on HSL translocation and cellular activity (Egan et al., 1992; Clifford et al., 2000; Sztalryd et al., 2003) . Nonetheless, significant TG hydrolase activity has been reported in cytosolic preparations and WAT organ cultures from ATGL-deficient mice Schweiger et al., 2006) and HSL activity accounted for ~40% of basal lipolysis in human differentiated adipocytes (Ryden et al., 2007) . Based on our findings, it seems likely that basal activity of HSL is sufficient to allow substantial NEFA mobilization from DG generated by ABHD5-dependent activation of ATGL, especially in the cellular model of white adipocytes. Additionally, our experiments revealed a significant (17-25%) component of ABHD5 ligand-induced lipolysis in 3T3-L1 cells that was dependent on HSL (BAY-sensitive), but independent of ATGL (Atglistatin-resistant). The mechanisms involved are presently uncertain; however, given that neither compounds nor ABHD5 directly interact with HSL (Sanders et al., 2015) , the mechanism is likely indirect and possibly cell type-specific. The presence of lipolysis that is dependent on ABHD5 yet independent of ATGL is thought to exist in skin (Radner et al., 2010) , and we speculate that ABHD5 ligands might be useful in uncovering the mechanisms involved.
Collectively, our work demonstrates that ABHD5 is a dominant locus of acute lipolysis regulation in adipocytes, and that ABHD5 is integral for both PKA-and ligand-mediated receptor-mediated signaling is suppressed by insulin or desensitization. As lipolysis is necessary and sufficient for brown adipocyte thermogenesis (Guerra et al., 1998; Ahmadian et al., 2011) , and also plays a critical role in catabolic adipose tissue remodeling Li et al., 2005; Mottillo et al., 2007) , it seems reasonable to suggest that ABHD5 ligands might be developed as sustained activators that promote fatty acid catabolism in the presence of hyperinsulinemia or where receptor-dependent signaling is compromised.
Several ATGL-independent roles for ABHD5 have also been described (Lord and Brown, 2012; Brown and Brown, 2017) . For example, ABHD5 has suggested tumor suppressor functions in colorectal carcinogenesis, potentially by regulating autophagic flux and AMPactivated protein kinase signaling Peng et al., 2016) . ABHD5 is also involved in skin barrier function by participating in ω-O-acylceramide biosynthesis (Radner et al., 2010; Grond et al., 2017) , in regulating hepatic triacylglyceride metabolism and steatosis (Radner et al., 2010; Lord et al., 2016) , as well as in macrophage phenotype/function (Goeritzer et al., 2014; Miao et al., 2014) . Thus, synthetic ligands may also help delineate additional ABHD5-mediated signaling events in a variety of conditions with potential therapeutic implications.
Limitations were that our study was conducted using murine models of adipose tissue lipolysis. Although preclinical and cellular models are integral in understanding protein function in a more controlled fashion, it is plausible that additional, and currently unknown, speciesdependent regulatory mechanisms may exist for eliciting full stimulation of ABHD5.
Additionally, although synthetic ABHD5 ligands clearly act downstream of cAMP and PKAdependent phosphorylation, it is conceivable that ABHD5 ligands may indirectly activate other phosphorylation-dependent signaling pathways that were not evaluated in the current study. 
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ISO in both 3T3-L1 (Fig. 5A) and BA (Fig. 5B) . In contrast, insulin failed to suppress lipolysis stimulated by synthetic ABHD5 ligands. ** Denotes significant effect of insulin on NEFA levels within the ISO-treated group (P<0.01). This article has not been copyedited and formatted. The final version may differ from this version. 
